Aortic arch atheroma

International Journal of Stroke

Volumn 1, Issue 2, 2006, Pages 74-80

  Zavala, Jorge A ^a   Amarrenco, Pierre ^b   Davis, Stephen M ^c   Jones, Elizabeth F ^c   Young, Dennis ^a   Macleod, Malcolm R ^a,d   Horky, Laura L ^a   Donnan, Geoffrey A ^a,c,e  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; INDAPAMIDE; PERINDOPRIL; SIMVASTATIN; WARFARIN;

ANTICOAGULATION; AORTA ARCH; ARTERY GRAFT; ATHEROMA; AUTOPSY; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY STENT; DACRON IMPLANT; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE SEVERITY; EMBOLISM; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; META ANALYSIS; NEUROPATHOLOGY; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SYSTEMATIC REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; CADAVER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; INTRACRANIAL EMBOLISM; RISK FACTORS;

EID: 33646144002     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2006.00026.x     Document Type: Review

References (68)

1. Bonita R: Epidemiology of stroke. Lancet 1992; 339(8789): 342-4.
2. Rothwell PM, Coull AJ, Silver LE et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366(9499): 1773-83.
3. Thrift AG, Dewey HM, Macdonell RA et al. Incidence of the major stroke subtypes: Initial findings from the north east Melbourne stroke incidence study (NEMESIS). Stroke 2001; 32(8): 1732-8.
4. Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org. 10172 in acute stroke treatment. Stroke 1993; 24(1): 35-41.
5. Elkind MS, Sacco RL: Stroke risk factors and stroke prevention. Semin Neurol 1998; 18(4): 429-40.
6. Petty GW, Brown RD Jr, Whisnant JP et al. Ischemic stroke subtypes: A population-based study of incidence and risk factors. Stroke 1999; 30(12): 2513-6.
7. Winter WJ Jr: Atheromatous emboli; a cause of cerebral infarction; report of two cases. AMA Arch Pathol 1957; 64(2): 137-42.
8. Tunick PA, Kronzon I: Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: A new finding seen by transesophageal echocardiography. Am Heart J 1990; 120(3): 658-60.
9. Amarenco P, Duyckaerts C, Tzourio C et al. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992; 326(4): 221-5.
10. Amarenco P, Cohen A, Baudrimont M et al. Transesophageal echocardiographic detection of aortic arch disease in patients with cerebral infarction. Stroke 1992; 23(7): 1005-9.
11. Strong JP, Restrepo C, Guzman M: Coronary and aortic atherosclerosis in New Orleans. II. Comparison of lesions by age, sex, and race. Lab Invest 1978; 39(4): 364-9.
12. Davila-Roman VG, Barzilai B, Wareing TH et al. Atherosclerosis of the ascending aorta. Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke 1994; 25(10): 2010-6.
13. Sen S, Oppenheimer SM, Lima J et al. Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke 2002; 33(4): 930-5.
14. Tribouilloy C, Peltier M, Colas L et al. Fibrinogen is an independent marker for thoracic aortic atherosclerosis. Am J Cardiol 1998; 81(3): 321-6.
15. Macleod MR, Amarenco P, Davis SM et al. Atheroma of the aortic arch: An important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 2004; 3(7): 408-14.
16. Tribouilloy CM, Peltier M, Iannetta Peltier MC et al. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Chest 2000; 118(6): 1685-9.
17. Elkind MS, Sciacca R, Boden-Albala B et al. Leukocyte count is associated with aortic arch plaque thickness. Stroke 2002; 33(11): 2587-92.
18. Montgomery DH, Ververis JJ, McGorisk G et al. Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study. J Am Coll Cardiol 1996; 27(1): 95-101.
19. Geraci A, Weinberger J: Natural history of aortic arch atherosclerotic plaque. Neurology 2000; 54(3): 749-51.
20. Geiringer E: Arteriosclerosis as a normal process of ageing. Rev Med Liege 1950; 5(20): 614-8.
21. Mendel T, Popow J, Hier DB et al. Advanced atherosclerosis of the aortic arch is uncommon in ischemic stroke: An autopsy study. Neurol Res 2002; 24(5): 491-4.
22. Lammie GA, Wardlaw JM: Small centrum ovale infarcts - a pathological study. Cerebrovasc Dis 1999; 9(2): 82-90.
23. Khatibzadeh M, Mitusch R, Stierle U et al. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996; 27(3): 664-9.
24. Pop G, Sutherland GR, Koudstaal PJ et al. Transesophageal echocardiography in the detection of intracardiac embolic sources in patients with transient ischemic attacks. Stroke 1990; 21(4): 560-5.
25. Toyoda K, Yasaka M, NAgata S, Yamaguchi T: Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke 1992; 23(8): 1056-61.
26. Fasseas P, Brilakis ES, Leybishkis B et al. Association of carotid artery intima-media thickness with complex aortic atherosclerosis in patients with recent stroke. Angiology 2002; 53(2): 185-9.
27. Acarturk E, Ozeren A, Sarica Y: Detection of aortic plaques by transesophageal echocardiography in patients with ischemic stroke. Acta Neurol Scand 1995; 92(2): 170-2.
28. Guo Y, Rosengart A, Mitasch R et al. Aortic plaque as a potential cause for cerebral ischemia. J Tongji Med Univ 1997; 17(3): 177-81.
29. Yonemura K, Kimura K, Hasegawa Y et al. Analysis of ischemic stroke in patients aged up to 50 years. Rinsho Shinkeigaku 2000; 40(9): 881-6.
30. Horowitz DR, Tuhrim S, Budd J et al. Aortic plaque in patients with brain ischemia: Diagnosis by transesophageal echocardiography. Neurology 1992; 42(8): 1602-4.
31. Agmon Y, Khandheria BK, Meissner I et al. Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol 2002; 89(3): 262-7.
32. Karalis DG, Chandrasekaran K, Victor MF et al. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 1991; 17:73-8.
33. Tunick PA, Perez JL, Kronzon I: Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991; 115(6): 423-7.
34. Kazui S, Levi CR, Jones EF et al. Risk factors for lacunar stroke: A case-control transesophageal echocardiographic study. Neurology 2000; 54(6): 1385-7.
35. Nihoyannopoulos P, Joshi J, Athanasopoulos G et al. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol 1993; 71(13): 1208-12.
36. Mitusch R, Tepe C, Stierle U et al. Determinants of arterial embolism with special reference to atheromatous changes of the thoracic aorta. Z Kardiol 1995; 84(3): 198-204.
37. Stone DA, Hawke MW, LaMonte M et al. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: A multiplane transesophageal echocardiographic study. Am Heart J 1995; 130(1): 105-8.
38. Di Tullio MR, Sacco RL, Gersony D et al. Aortic atheromas and acute ischemic stroke: A transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996; 46(6): 1560-6.
39. Tenenbaum A, Fisman EZ, Schneiderman J et al. Disrupted mobile aortic plaques are a major risk factor for systemic embolism in the elderly. Cardiology 1998; 89(4): 246-51.
40. Nakayama K, Yamamuro A, Ikuno Y et al. Evaluation of patients with cerebral infarction using transesophageal echocardiography: atherosclerotic changes in the thoracic aorta and the branches of the aortic arch. J Cardiol 1998; 32(1): 21-30.
41. Ferrari E, Vidal R, Chevallier T et al. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: Benefit of oral anticoagulants. J Am Coll Cardiol 1999; 33(5): 1317-22.
42. Matsumura Y, Osaki Y, Fukui T et al. Protruding atherosclerotic aortic plaques and dyslipidaemia: Correlation to subtypes of ischaemic stroke. Eur J Echocardiogr 2002; 3(1): 8-12.
43. Amarenco P, Cohen A, Tzourio C et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331(22): 1474-9.
44. Jones EF, Kalman JM, Calafiore P et al. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke 1995; 26(2): 218-24.
45. Tunick PA, Rosenzweig BP, Katz ES et al. High risk for vascular events in patients with protruding aortic atheromas: A prospective study. J Am Coll Cardiol 1994; 23(5): 1085-90.
46. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French study of aortic plaques in Stroke Group. N Engl J Med 1996; 334(19): 1216-21.
47. Mitusch R, Doherty C, Wucherpfennig H et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997; 28(1): 36-9.
48. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med 1998; 128(8): 639-47.
49. Kazui S, Levi CR, Jones EF et al. Lacunar stroke: Transoesophageal echocardiographic factors influencing long-term prognosis. Cerebrovasc Dis 2001; 12(4): 325-30.
50. Gao S, Wong KS, Hansberg T et al. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 2004; 35(12): 2832-6.
51. Kern R, Steinke W, Daffertshofer M et al. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005; 65(6): 859-64.
52. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1991; 325(7): 445-53.
53. Demopoulos LA, Tunick PA, Bernstein NE et al. Protruding atheromas of the aortic arch in symptomatic patients with carotid artery disease. Am Heart J 1995; 129(1): 40-4.
54. Rundek T, Di Tullio MR, Sciacca RR et al. Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients. Stroke 1999; 30(12): 2683-6.
55. Castellanos M, Serena J, Segura T et al. Atherosclerotic aortic arch plaques in cryptogenic stroke: A microembolic signal monitoring study. Eur Neurol 2001; 45(3): 145-50.
56. Viguier A, le Pavy A, Massabuau P et al. Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis. J Neurol 2001; 248(9): 768-71.
57. Fleck TM, Koinig H, Czerny M et al. Impact of surgical era on outcomes of patients undergoing elective atherosclerotic ascending aortic aneurysm operations. Eur J Cardiothorac Surg 2004; 26(2): 342-7.
58. Lancaster G, Lovoulos CJ, Moussouttas M et al. Aortic arch replacement for recurrent cerebral embolization. Ann Thorac Surg 2002; 73(1): 291-4.
59. Hausmann D, Gulba D, Bargheer K et al. Successful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992; 327(7): 500-1.
60. Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002; 106(23): 2884-7.
61. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360(9326): 7-22.
62. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358(9287): 1033-41.
63. Dressler FA, Craig WR, Castello R et al. Mobile aortic atheroma and systemic emboli: Efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998; 31(1): 134-8.
64. Blackshear JL, Zabalgoitia M, Pennock G et al. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am J Cardiol 1999; 83(3): 453-5, A9.
65. Mehta SR, Yusuf S: The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000; 21(24): 2033-41.
66. Muller C, Buttner HJ, Petersen J et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000; 101(6): 590-3.
67. Albers GW, Amarenco P: Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients. Stroke 2001; 32(12): 2948-9.
68. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet 2004; 364(9431): 331-7.